Skip to main content

Want a detailed portfolio tracker?

Abpro Holdings, Inc Common Stock (ABP) P/E (2025 - 2026)

Abpro Holdings, Inc Common Stock (ABP) P/E from Mar 31, 2025 to Jul 21, 2026. The TTM Abpro Holdings, Inc Common Stock (ABP) P/E is -0.22. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Abpro Holdings, Inc Common Stock (ABP)

YearP/EChange
2026-0.22-87.66%
2025-1.75N/A

Comparison Abpro Holdings, Inc Common Stock (ABP) P/E with competitors

Abpro Holdings, Inc Common Stock (ABP) P/E is -0.22.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.79%
NBYStablecoin Development Corp0.00-101.99%
ENLVEnlivex Ltd0.07-134.64%
FGENFibroGen Inc0.24-211.17%
CHRSCoherus Biosciences Inc0.85-492.98%
FBIOFortress Biotech Inc0.95-539.53%
ORMPOramed Pharmaceuticals Inc1.50-796.12%
AGENAgenus Inc3.01-1493.85%
INVAInnoviva Inc3.15-1560.73%
VXRTVaxart Inc3.55-1744.00%
CRMDCorMedix Inc3.63-1780.45%
CVACCureVac N.V.4.45-2158.94%
GLPGGalapagos NV4.86-2350.31%
SRPTSarepta Therapeutics Inc4.88-2361.06%
ABEOAbeona Therapeutics Inc5.39-2595.13%
ABUSArbutus Biopharma Corp5.60-2691.51%
SPROSpero Therapeutics Inc6.23-2984.60%
CGENCompugen Ltd6.31-3024.20%
RIGLRigel Pharmaceuticals6.87-3282.68%
SLXNSilexion Therapeutics Corp7.30-3479.06%
OMEROmeros Corporation9.26-4388.04%
AUPHAurinia Pharmaceuticals Inc9.58-4539.12%
PLXProtalix BioTherapeutics Inc10.89-5143.99%
ACADAcadia Pharmaceuticals Inc11.73-5531.88%
TBPHTheravance Biopharma Inc12.26-5779.02%
ADMAAdma Biologics Inc12.42-5851.27%
HRMYHarmony Biosciences Holdings Inc13.82-6500.61%
SABSSAB Biotherapeutics Inc14.14-6646.96%
NAGENiagen Bioscience Inc14.82-6962.79%
INCYIncyte Corp15.82-7427.97%
REGNRegeneron Pharmaceuticals Inc15.86-7443.77%
PBYIPuma Biotechnology Inc17.32-8119.51%
CPRXCatalyst Pharmaceuticals Inc17.44-8176.75%
EXELExelixis Inc17.54-8222.46%
TGTXTG Therapeutics Inc18.97-8883.84%
MDXGMimedx Group Inc20.55-9618.59%
XOMAXOMA Royalty Corp22.87-10694.35%
ARGXArgen X SE24.30-11353.55%
CTMXCytomX Therapeutics Inc24.82-11595.82%
XOMAOXOMA Royalty Corp25.34-11838.38%
HALOHalozyme Therapeutics Inc25.62-11967.55%
XOMAPXOMA Royalty Corp25.67-11989.04%
VRTXVertex Pharmaceuticals Inc27.99-13065.68%
RPRXRoyalty Pharma plc - Class A28.69-13386.55%
SLNOSoleno Therapeutics Inc29.02-13538.37%
ASNDAscendis Pharma A/S30.09-14034.04%
LGNDLigand Pharmaceuticals Inc - Class B37.91-17658.84%
APLSApellis Pharmaceuticals Inc39.02-18172.57%
BMRNBiomarin Pharmaceutical Inc42.21-19650.30%
KRYSKrystal Biotech Inc45.34-21100.70%
ONCBeiGene Ltd69.54-32307.47%
PHARPharming Group N.V.75.03-34847.90%
TECHBio-Techne Corp101.96-47321.76%
VCELVericel Corp109.92-51009.79%
ALNYAlnylam Pharmaceuticals Inc117.96-54735.23%
GMABGenmab140.29-65075.31%
TLXTelix Pharmaceuticals Ltd162.15-75200.67%
CORTCorcept Therapeutics Inc212.86-98684.42%